MU AND KAPPA OPIOID RECEPTOR EXPRESSION IN THE MEDIOBASAL HYPOTHALAMUS AND EFFECTIVENESS OF SELECTIVE ANTAGONISTS ON PROLACTIN RELEASE DURING LACTATION

被引:15
|
作者
Tavakoli-Nezhad, M. [1 ]
Arbogast, L. A. [1 ]
机构
[1] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA
关键词
lactation; tuberoinfundibular; dopamine; endogenous opioid peptides; median eminence; rat; TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS; CENTRAL-NERVOUS-SYSTEM; PROOPIOMELANOCORTIN GENE-EXPRESSION; MESSENGER-RNA EXPRESSION; RIBONUCLEIC-ACID LEVELS; IMMUNOHISTOCHEMICAL LOCALIZATION; POSTERIOR PITUITARY; SUCKLING STIMULUS; ARCUATE NUCLEUS; NEURAL ACTIVITY;
D O I
10.1016/j.neuroscience.2009.12.066
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Endogenous opioid peptides are involved in prolactin release during lactation, in part by decreasing tuberoinfundibular dopaminergic (TIDA) neuronal activity. Both mu (mu) and kappa (kappa) opioid receptors have a role in the suckling-induced prolactin rise after 4-5 h up deprivation. The aim of this study was to investigate effects of mu opioid receptor antagonist, beta-funaltrexamine (beta-FNA), and kappa opioid receptor antagonist, nor-binaltorphimine (nor-BNI), on prolactin secretion and TIDA neuronal activity in lactating rats after 18 h pup deprivation. After 4 h separation from pups, the suckling-induced prolactin rise was abolished by 16 mu g nor-BNI and 5 mu g beta-FNA, coincident with increased dihydroxyphenylacetic acid (DOPAC):dopamine ratio in the stalk-median eminence (SME). However, after 18 h pups separation, these same doses of nor-BNI and beta-FNA did not alter the prolactin surge or DOPAC:dopamine ratios in the SME. Higher doses of nor-BNI (32 mu g) and beta-FNA (10 mu g) were required to inhibit suckling-induced prolactin secretion. beta-FNA (10 mu g) increased the DOPAC:dopamine ratio in the SME, whereas nor-BNI (32 mu g) treatment had no effect. The mu and kappa opioid receptor mRNA levels in the mediobasal hypothalamus were similar to suckled control rats after 4 h pup deprivation, but increased 1.4-fold after 18 h pup deprivation. These data support involvement of endogenous opioidergic systems in the suckling-induced prolactin rise after a prolonged (18 h) period of pup deprivation, as well as the shorter (4 h) pup deprivation period previously reported. Suppression of TIDA neuronal activity likely played a part in mu opioid receptor input to the suckling-induced prolactin rise after both 4 h and 18 h separation, whereas non-dopaminergic input was implicated with kappa opioid receptors after 18 h pup deprivation. Increased mu and kappa opioid receptors gene expression in the mediobasal hypothalamus may contribute to reduced effectiveness of opioid receptor antagonists to block suckling-induced prolactin release after 18 h pup deprivation. (C) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:359 / 367
页数:9
相关论文
共 50 条
  • [41] CYCLIC SOMATOSTATIN ANALOGS AS POTENT ANTAGONISTS AT MU-OPIOID, BUT NOT DELTA-OPIOID AND KAPPA-OPIOID RECEPTORS MEDIATING PRESYNAPTIC INHIBITION OF NEUROTRANSMITTER RELEASE IN THE BRAIN
    MULDER, AH
    WARDEH, G
    HOGENBOOM, F
    KAZMIERSKI, W
    HRUBY, VJ
    SCHOFFELMEER, ANM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (01) : 1 - 6
  • [42] Development of mu opioid receptor selective antagonists based on homology modeling and "message-address" concept
    Li, Guo
    Aschenbach, Lindsey C.
    Stevens, David L.
    Gabra, Bichoy H.
    Selley, Dana E.
    Dewey, William L.
    Westkaemper, Richard B.
    Zhang, Yan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [43] Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat
    Spreekmeester, E
    Rochford, J
    PSYCHOPHARMACOLOGY, 2000, 148 (01) : 99 - 105
  • [44] Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat
    E. Spreekmeester
    J. Rochford
    Psychopharmacology, 2000, 148 : 99 - 105
  • [45] Effects of agonists with mixed efficacy profiles at the mu and kappa opioid receptor on amphetamine-mediated dopamine release
    Bosse, Kelly E.
    Bradbury, Faye A.
    Jutkiewicz, Emily M.
    Husbands, Steve M.
    Gnegy, Margaret E.
    Traynor, John R.
    FASEB JOURNAL, 2008, 22
  • [46] DAMGO, A MU-OPIOID RECEPTOR-SELECTIVE LIGAND, DISTINGUISHES BETWEEN MU-OPIOID AND KAPPA-OPIOID RECEPTORS AT A DIFFERENT REGION FROM THAT FOR THE DISTINCTION BETWEEN MU-OPIOID AND DELTA-OPIOID RECEPTORS
    MINAMI, M
    ONOGI, T
    NAKAGAWA, T
    KATAO, Y
    AOKI, Y
    KATSUMATA, S
    SATOH, M
    FEBS LETTERS, 1995, 364 (01) : 23 - 27
  • [47] Opioid receptor agonists selective for mu and kappa receptors attenuate methamphetamine-induced behavioral sensitization in the mouse
    Toyoshi, T
    Ukai, M
    Kameyama, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1996, 19 (03) : 369 - 374
  • [48] Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats
    Bo Zhang
    Yueping Hou
    James L. Voogt
    Endocrine, 2004, 25 : 131 - 136
  • [49] Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats
    Zhang, B
    Hou, YP
    Voogt, JL
    ENDOCRINE, 2004, 25 (02) : 131 - 136
  • [50] Modulation of humoral immune response by central administration of leucine-enkephalin: Effects of mu, delta and kappa opioid receptor antagonists
    Radulovic, J
    Mancev, Z
    Stanojevic, S
    Vasiljevic, T
    KovacevicJovanovic, V
    Pesic, G
    JOURNAL OF NEUROIMMUNOLOGY, 1996, 65 (02) : 155 - 161